Lifetech Pharmaceutical (002393.SZ): The controlled release tablets of Glipizide have been approved for market authorization.

Intelligent Finance and Economics APP news, Lisheng Pharmaceutical (002393.SZ) announced that recently, the company received the "Drug Registration Certificate" (batch number: 2026S01900) for the 5mg specification of Glimepiride controlled release tablets issued by the National Medical Products Administration. The above-mentioned drug has passed the drug market authorization application. By obtaining the market authorization application for this drug, it will further enrich the company's product line of endocrine system drugs and enhance the company's market competitiveness. According to relevant national policies, Glimepiride controlled release tablets are approved for production as Category 4 chemical drugs, equivalent to passing consistency evaluation.